Intech Investment Management LLC Increases Stake in Danaher Corporation $DHR

Key Points

• Intech Investment Management LLC has increased its stake in Danaher Corporation by 46.8%, now owning 14,591 shares valued at approximately $2.99 million.
• Danaher recently reported a quarterly earnings per share (EPS) of $1.80, exceeding estimates and showing a 3.4% year-over-year revenue increase to $5.94 billion.
• The company declared a quarterly dividend of $0.32 per share, with an annualized yield of 0.7%, to be paid on October 31st.

Intech Investment Management LLC grew its stake in Danaher Corporation (NYSE:DHR - Free Report) by 46.8% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 14,591 shares of the conglomerate's stock after buying an additional 4,653 shares during the quarter. Intech Investment Management LLC's holdings in Danaher were worth $2,991,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. Bank Pictet & Cie Europe AG boosted its stake in shares of Danaher by 22.8% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock valued at $44,241,000 after buying an additional 35,730 shares during the period. Tema Etfs LLC purchased a new position in shares of Danaher in the 4th quarter valued at about $1,577,000. Strategic Wealth Partners Ltd. boosted its stake in shares of Danaher by 14.4% in the 4th quarter. Strategic Wealth Partners Ltd. now owns 1,502 shares of the conglomerate's stock valued at $345,000 after buying an additional 189 shares during the period. Triavera Capital LLC purchased a new position in shares of Danaher in the 4th quarter valued at about $8,313,000. Finally, Tidal Investments LLC boosted its stake in shares of Danaher by 43.0% in the 4th quarter. Tidal Investments LLC now owns 75,704 shares of the conglomerate's stock valued at $17,378,000 after buying an additional 22,757 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.20% of the stock is owned by company insiders.

Danaher Price Performance

Danaher stock opened at $190.07 on Monday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The business has a 50 day simple moving average of $201.21 and a 200-day simple moving average of $198.78. The stock has a market capitalization of $136.10 billion, a PE ratio of 40.44, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. During the same quarter in the prior year, the business earned $1.72 earnings per share. The company's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher's dividend payout ratio is 27.23%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on DHR shares. Scotiabank upgraded Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a research note on Friday, July 11th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Royal Bank Of Canada set a $241.00 target price on Danaher in a research note on Tuesday, September 2nd. UBS Group decreased their target price on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Seventeen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $246.35.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.